LSEGWe closed London's marketsRead the story →
← OTA LEADERS

OTA LEADERSHIP INDEX

Thomas Seyfried

ARCHETYPE

The Visionary

The future, and what is barely possible, reads round the next corner.

Thomas Seyfried reads as The Visionary because he has spent decades arguing, against mainstream oncology consensus, that cancer is primarily a metabolic disease rather than a genetic one. From Boston College he has reframed how the disease should be understood and treated, advancing ketogenic metabolic therapy as a clinical intervention the establishment has been slow to examine. He does not follow institutional momentum. He builds an alternative framework outward from the evidence itself.

IN THEIR WORDS, WHY VISIONARY

The field doesn't understand what I'm saying about the origin of cancer. Everything comes back to the mitochondria and all chronic diseases and cancer are the result of damage to this. The science is telling us this, but the field has yet to accept it.

CHALLENGING MAINSTREAM CANCER PARADIGM

There's 1,700 people a day in this country dying from cancer. That's 70 an hour. And it gets worse every single year. When are the people gonna wake up?

URGENCY AROUND CANCER MORTALITY

We have given hope to the hopeless. We can manage cancer effectively without toxicity. I will put up our metabolic therapy against any trial from any of these pharmaceutical companies.

CONFIDENCE IN METABOLIC THERAPY APPROACH

THE DIARY OF A CEO

The Diary of a CEO: “Leading Cancer Researcher: They’re Ignoring My Research, Cancer Patients Must Know This!”

LISTEN AT THE SOURCE ↗
Thomas's full six-dimension Leadership Index profile is held pending their validation. The archetype shown is the OTA analyst-rated read. How we read a leader →

THE RECORD IS CHECKABLE